Metastatic risk and resistance to BRAF inhibitors in melanoma defined by selective allelic loss of ATG5
通过 ATG5 的选择性等位基因缺失定义黑色素瘤的转移风险和对 BRAF 抑制剂的耐药性
期刊:Autophagy
影响因子:14.6
doi:10.1080/15548627.2016.1199301
María García-Fernández, Panagiotis Karras, Agnieszka Checinska, Estela Cañón, Guadalupe T Calvo, Gonzalo Gómez-López, Metehan Cifdaloz, Angel Colmenar, Luis Espinosa-Hevia, David Olmeda, María S Soengas
